Crescita Therapeutics Inc (CTX) — Cash Flow Quality Index
Crescita Therapeutics Inc (CTX) has a Cash Flow Quality Index of 1.56x as of September 2025. Operating cash flow of CA$1.17 Million exceeds net income of CA$753.00K, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of Crescita Therapeutics Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Crescita Therapeutics Inc Cash Flow Quality Index (2018–2022)
Historical Cash Flow Quality Index for Crescita Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Crescita Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Crescita Therapeutics Inc (2018–2022)
Year-by-year earnings quality comparison for Crescita Therapeutics Inc. For live market cap and the full company financial profile, see CTX market cap overview.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.18x | CA$-1.02 Million | CA$862.00K | ▼ -100.8% |
| 2020 | 151.57x | CA$5.61 Million | CA$37.00K | ▲ +5198.9% |
| 2019 | 2.86x | CA$5.31 Million | CA$1.85 Million | ▲ +563.7% |
| 2018 | -0.62x | CA$-1.48 Million | CA$2.40 Million | — |